Insights & Discussion
Chinese herbal medicine usage in children with asthma can reduce their risk of hospitalization.
The study used data from one million individuals randomly selected from the National Health Insurance Research Database's Registry of Beneficiaries. Children under 18 years old diagnosed with asthma were followed from the year 2000 to 2012. These patients were classified into two groups: the Chinese Herbal Medicine (CHM) group and the non-CHM group. The Kaplan-Meier survival curve and Cox proportional hazard regression model were utilized to estimate the adjusted hazard ratio of the two groups and to determine the correlation between the number of cumulative days the CHM was used and consequent hospitalizations due to asthma.
After adjusting for variables such as gender, age, comorbidities, and the total numbers of asthma medications taken, it was found that users of CHM had a reduced risk of hospitalization due to asthma compared to non-CHM users. Children older than six years who used CHM therapy for more than 180 days demonstrated a significant reduction in the risk of subsequent hospitalization for asthma.
Discover Related Insights
Pomegranate extract supplements can help improve clinical symptoms and lower blood cell counts associated with inflammation in patients with allergic asthma.
2023 Frontiers in Pharmacology Does pomegranate extract supplementation improve the clinical symptoms of patients with allergic asthma? A double-blind, randomized, placebo-controlled trial Hosseini SA, Shateri Z, Abolnezhadian F, Maraghi E, Haddadzadeh Shoushtari M, Zilaee M
Randomised Controlled Trial Pomegranate
In this study, 64 participants with mild to moderate allergic asthma were randomly divided into two groups: a control group which was given placebo capsules and an intervention group which was given pomegranate extract capsules. The intervention group was administered a dosage of 250 milligrams of pomegranate extract twice daily over a period of eight weeks. The clinical symptoms and blood cell counts of all the participants were measured before starting the intervention and post the completion of it.
The results of the study indicated that the group which was given pomegranate extract exhibited considerable improvement in clinical symptoms like shortness of breath and restrictions on activity, as compared to the control group. Additionally, the participants in the intervention group displayed a substantive drop in eosinophil, basophil, and neutrophil counts. Notably, there was a statistically significant difference in the neutrophil and eosinophil levels between the two groups, which suggests that pomegranate extract supplementation might have potential therapeutic benefits for asthma patients.
Chinese herbal medicines (CHMs) possess multiple advantages, including multiple targets, pathways, and low toxicity, for the treatment of prostate cancer.
2023 Chinese Herbal Medicines Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice Kong F, Wang C, Zhang J, Wang X, Sun B, Xiao X, et al.
Review Article Chinese Herbal Medicine Prostate Cancer
The research team undertook an in-depth review of experimental research and clinical practices related to the use of CHMs for prostate cancer treatment, with the data being sourced from PubMed, Embase, and Web of Science. The focus of the review was on recent studies published within the last five years. The research identified five CHM formulas and six single CHM extracts, along with 12 CHM-derived compounds.
The research findings demonstrated that CHMs induced apoptosis, autophagy, and cell cycle arrest in prostate cancer cells, and concurrently suppressed angiogenesis, proliferation, and cell migration. The CHMs also displayed efficacy in overturning drug resistance and in enhancing anti-tumor immunity. The modes of action were identified as the phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin, androgen receptor, epidermal growth factor receptor, and Wnt/beta-catenin signaling pathways which are known to play key roles in the development of prostate cancer. Additionally, the researchers discussed the benefits of CHMs in treating hormone-sensitive and castration-resistant prostate cancer.
Chinese herbal medicine has shown effectiveness in treating amenorrhea caused by antipsychotic drugs, with an overall treatment effectiveness rate of 0.91, but the duration of treatment is relatively long, and further research is required to explore its application in this context.
2022 Journal of Ethnopharmacology Traditional Chinese herbal medicine in treating amenorrhea caused by antipsychotic drugs: Meta-analysis and systematic review Liu L, Li H, Tan G, Ma Z
Systematic Review Antipsychotic Chinese Herbal Medicine
The passage presents a meta-analysis of traditional Chinese herbal medicine for treating amenorrhea caused by antipsychotic drugs. Chinese herbal medicine was found to be effective, with an overall success rate of 0.91, but the treatment duration was often lengthy, exceeding three months. Commonly used herbal remedies included Danggui, Chuanxiong, Taoren, Honghua, Gancao, Fuling, Baizhu, Xiangfu, Chaihu, Shudihuang, and Baishao. The study suggests that Chinese herbal medicine can be a viable option for managing this condition, but further research is needed to understand its mechanisms and optimize treatment approaches.
Chinese Herbal Medicines may help with chronic sinusitis and acute rhinosinusitis symptoms with LDXGT and modified CEZS working well, especially for CRS.
2022 PLOS One Chinese herbal therapy in the management of rhinosinusitis—A systematic review and meta-analysis Cui J, Lin W, May BH, Luo Q, Worsnop C, Zhang AL, et al.
Systematic Review Chinese Herbal Medicine Rhinosinusitis
The review assessed the effectiveness of Chinese herbal medicines (CHMs) in treating chronic rhinosinusitis (CRS) and acute rhinosinusitis (ARS). It found that certain CHMs showed potential in improving CRS symptoms and measures related to sinus health, with the best evidence for LDXGT and modified CEZS formulas. However, more blinded randomized controlled trials are needed to confirm these findings.
HuoXiang ZhengQi (HQXXD) may be a safe and effective treatment for Chronic Cough Variant Asthma (CVA), improving clinical efficacy and airway responsiveness while reducing recurrence rates.
2022 Evidence-Based Complementary and Alternative Medicine The Effectiveness and Safety of Huangqi Xixin Decoction for Cough Variant Asthma: A Systematic Review and Meta-Analysis Wang C, Xia Q, Hu B, Jiang W, Zhang H
Systematic Review Cough Huang Qi Huangqi Xixin decoction
HuoXiang ZhengQi (HQXXD) for Chronic Cough Variant Asthma (CVA) was systematically evaluated. The HQXXD group showed significantly higher total effective rates of clinical efficacy and airway responsiveness compared to the control group, while the recurrence rate was lower. Adverse reactions were not reported in HQXXD treatment, indicating its safety for CVA patients.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.